[1]
V. Ankudavičius, “REVIEW OF FIVE YEARS OF CLINICAL DATA ON THE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER WITH PEMBROLIZUMAB AND CHEMOTHERAPY IN PD-L1 EXPRESSION-NEGATIVE PATIENTS”, PIA, vol. 8, no. 2, pp. 201-206, Sep. 2024.